PRAH News
Archived Headlines
- Week ahead: 10 US IPOs planned for the week of Nov 10 as IPO market hits 250 with Virgin America 11/09/14
- Test taking for hire: PRA Health Sciences sets terms for $400 million IPO 11/03/14
- Testing for hire: INC Research files for a $150 million IPO 10/06/14
- Trial by hire: KKR's clinical trial outsourcer PRA Health Sciences files for a $375 million IPO 09/08/14
US IPO Week Ahead: Medpace and three others are on pace for IPOs
Four companies are set to raise a combined $270 million in the week ahead. Most notable deal Medpace, a contract research organization focused on biotechs, is joined by two potential customers: Protagonist Therapeutics and Motif Bio. Thanks to insider support,...read more
Renaissance IPO Index - Notice of September 2015 Quarterly Changes
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s...read more
US IPO Weekly Recap: Virgin America flies high as IPO market reaches 250 with 9 new offerings
9 companies went public this week, raising $2 billion in the IPO market as year-to-date issuance surpassed 250 IPOs, almost 25% more than at this point last year. 3 large PE-backed deals, including two LBOs, each traded up over 10% and represented 79% of...read more
CRO PRA Health Sciences prices IPO at $18, below the range
PRA Health Sciences, one of the largest global contract research organizations (CROs), raised $306 million by offering 17 million shares (100% primary) at $18, below the $20-$23 range. PRA had initially planned to offer 18.6 million shares, however, private...read more